College of Medicine, Pennsylvania State University, United Statesย ๐
Dr. Rashmi Kumari, R.Ph., Ph.D., is a distinguished researcher and educator with over a decade of experience in neural-behavioral sciences, cardiovascular pharmacology, and drug development. She has contributed significantly to understanding diabetes, stroke, and blood-brain barrier permeability through her extensive research. As an Assistant Professor at the College of Medicine, Hershey, PA, she leads groundbreaking studies on stroke recovery in diabetic patients. With more than 10 research publications in reputed scientific journals, Dr. Kumari has established herself as a key figure in her field. She is also an active member of several professional organizations, including the American Diabetes Association and the American Heart Association.
Profile
Orcid
Education ๐
Dr. Rashmi Kumari earned her Ph.D. in Pharmacology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, where she explored the interaction of vasoactive peptides in myocardial reperfusion injury. She also holds an M.S. in Drug Assay (Pharmacology) from AIIMS, focusing on the pharmacological modulation of myocardial stunning. Her academic journey began with a Bachelor of Pharmacy from Muzaffarpur Institute of Technology, India. Her rigorous academic training laid the foundation for her exceptional contributions to cardiovascular and neural pharmacology research.
Professional Experience ๐ผ
Dr. Kumari is currently an Assistant Professor in the Department of Neural-Behavioral Sciences at the College of Medicine, Hershey, PA. Her research primarily focuses on type 2 diabetic mouse models of stroke and the impact of blood-brain barrier permeability on stroke recovery. Previously, she worked as a Clinical Pharmacist at the Southeastern Veterans Center, managing medication verification and patient care. She has also held research roles at Hershey Medical Center, where she led projects on neurogenesis, inflammation, and stroke rehabilitation in diabetic models. Her industry experience includes working as an Associate Research Scientist at Zydus Cadila Research Centre, leading new drug discovery programs.
Research Interests ๐ฌ
Dr. Kumariโs research is centered on diabetes, stroke, and blood-brain barrier permeability. She investigates the pathophysiology of stroke in diabetic patients using experimental mouse models. Her studies aim to develop therapeutic interventions that improve stroke recovery by targeting inflammation and neurogenesis. She has extensively worked on hypoxic-ischemic injury models, hemorrhagic stroke models, and neuronal regeneration techniques. Her research contributes to understanding stroke-induced brain damage and finding innovative treatments to mitigate long-term effects in diabetic patients.
Awards & Recognitions ๐
Dr. Kumari has received several prestigious awards, including the Servier Young Investigator Award from Institut de Recherche International Servier, France. She was also honored with the Senior Research Fellowship from the Indian Council of Medical Research and the National Merit Scholarship awarded by the Government of India. Additionally, she holds professional certifications such as Pharmacist License RP450259, HeartSaver CPR Certification, and Immunization Certification, highlighting her expertise in both clinical and research domains.
Publications ๐
Kumari R, et al. (2009). PPAR-ฮณ agonist promotes early inflammatory responses in diabetic mouse during stroke recovery. Penn State Diabetic Research Retreat ๐
Kumari R, et al. (2007). Darglitazone improves stroke recovery in diabetic ob/ob mice. Penn State Diabetic Research Retreat ๐
Kumari R, Simpson IA. (2006). Diabetic & Stroke. 11th EASD Meeting on Diabetes Research, Oxford ๐
Kumari R, et al. (2006). Impaired wound healing in diabetic mouse brain following stroke. Penn State Diabetes Research Retreat ๐
Kumari R, et al. (2005). Impaired Wound Healing in Diabetic Ischemic Brain Injury. Mid-Atlantic Diabetes Symposium, NIH ๐
Kumari R, et al. (2000). Effect of HOE-140, a bradykinin B2 receptor antagonist, in feline myocardial ischemic-reperfusion injury. Indian Pharmacological Society Conference ๐
Kumari R, et al. (1999). ACE-Inhibitor and Angiotensin (AT1) receptor blocker in feline myocardial ischemic-reperfusion injury: A comparative study. International Congress on Frontiers in Pharmacology ๐
Conclusion ๐
Dr. Rashmi Kumari is highly suitable for the Best Researcher Award, given her pioneering work in neural and cardiovascular pharmacology. Her research has significant implications for stroke recovery in diabetic patients, a field with critical real-world applications. Strengthening her global research network and increasing her publication footprint in high-impact journals could further elevate her profile. Overall, she is a remarkable candidate with a strong track record of scientific excellence and innovation. ๐